Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

A new study shows low rates of pre-exposure prophylaxis (PrEP) prescribing to sexual and gender minority individuals living ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

New guidelines recommended by WHO will need to be backed with funding to be implemented at scale in affected communities.

As Black women are being hit with new HIV cases, stars such as Tamar Braxton is unapologetically shining a light on HIV ...

Chicago, Cook County and Illinois are on the cusp of ending the HIV epidemic in our city, county and state. But that progress ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

Tamar Braxton has announced a new brand partnership with Gilead Sciences. The music veteran will help educate and raise ...

Three decades after Rae Lewis-Thornton became the face of HIV, the virus is still a major threat to Black women. She and experts explore why.

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...